Log in to save to my catalogue

Prevention of CNS relapse in diffuse large B-cell lymphoma

Prevention of CNS relapse in diffuse large B-cell lymphoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_907037041

Prevention of CNS relapse in diffuse large B-cell lymphoma

About this item

Full title

Prevention of CNS relapse in diffuse large B-cell lymphoma

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2011-12, Vol.12 (13), p.1258-1266

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary CNS relapse occurs in about 5% of patients during the course of diffuse large B-cell lymphoma and entails a dismal prognosis. This consideration has led to the adoption of CNS prophylaxis, although known risk factors do not allow for an accurate prediction of CNS recurrences because they have insufficient sensitivity and specificity. Here,...

Alternative Titles

Full title

Prevention of CNS relapse in diffuse large B-cell lymphoma

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_907037041

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_907037041

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(11)70140-1

How to access this item